Questions about cancer? Freephone 1800 200 700 Irish Cancer Society Nurseline

Major merit award for Irish Oncologist

Medicine Weekly, 30 October 2002

Consultant Medical Oncologist Dr John Crown has received a merit award from the European Society of Medical Oncology for his and the anglo-celtic group’s breast cancer research work, AC-01 (ICORG study 97-02).

Announced at the Society’s meeting in Nice, France, last week, Dr. Crown’s presentation title was ‘Failure of adjuvant peripheral blood progenitor-supported high-dose chemotherapy to improve the prognosis of patients with high-risk breast cancer in a randomized trial with low treatment-related mortality: The Anglo-Celtic 1 Study’.

Dr. Crown is understood to be the first Irish investigator to have received such an award. The abstract was rated number two out of more than 500 submitted research reports from European and international research teams.

Three other ICORG investigators played a significant part at the meeting in Nice. Prof Patrick Johnston from Belfast City Hospital chaired the session on ‘The impact of molecular markers on clinical outcome in colorectal cancer’.

Dr John Kennedy, St. James’s Hospital, chaired a session on ‘Strategies for managing metastatic breast cancer’, while Dr John McCaffrey, Mater Hospital, critically analysed an important positive phase 2 randomized trial of treatment options in patients with hormone refractory prostate cancer.